SARS-CoV-2 immunochromatographic IgM/IgG rapid test in pregnancy: A false friend?
Marta FabreS Ruiz-MartinezM E Monserrat CanteraA Cortizo GarridoZ Beunza FabraM PeranR BenitoP MateoC PaulesD OrosPublished in: Annals of clinical biochemistry (2020)
Our data suggest that although immunochromatographic assay rapid tests may be a fast and profitable screening tool for SARS-CoV-2 infection, they may have a high false positive rate and low positive predictive value in pregnant women. Therefore, immunochromatographic assay for qualitative detection of SARS-CoV-2 IgG/IgM antibodies must be verified by other test in pregnant patients.
Keyphrases
- sars cov
- pregnant women
- loop mediated isothermal amplification
- respiratory syndrome coronavirus
- end stage renal disease
- high throughput
- chronic kidney disease
- ejection fraction
- newly diagnosed
- pregnancy outcomes
- systematic review
- prognostic factors
- peritoneal dialysis
- preterm birth
- electronic health record
- big data
- single cell
- patient reported